|
|
||||||||
a Department of Anesthesiology, University Medical Center Utrecht, Utrecht, the Netherlands
b Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands
c Department of Cardiothoracic Surgery, University Medical Center Utrecht, Utrecht, the Netherlands
d Department of Psychiatry, University Medical Center Utrecht, Utrecht, the Netherlands
e Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands
Accepted for publication August 15, 2007.
* Address correspondence to Dr van Dijk, University Medical Center Utrecht, Division of Perioperative and Emergency Care (Mail stop Q.04.2.313), PO Box 85500, Utrecht, 3508 GA, the Netherlands (Email: d.vandijk{at}umcutrecht.nl).
| Abstract |
|---|
|
|
|---|
Methods: Psychologists repeatedly administered a battery of seven neuropsychological tests with eight main variables to 112 subjects without known coronary artery disease, with a time interval of 5 years. Cognitive decline was defined as deterioration in performance beyond normal variation in at least two of the eight main variables. The incidence of cognitive decline in the control subjects was compared with the incidence of cognitive decline in the 281 participants of the Octopus Study, who underwent coronary artery bypass graft surgery 5 years earlier. Patients and control subjects were age-matched.
Results: After 5 years, cognitive outcome could be determined in 99 of 112 control subjects (88%) and 240 of 281 coronary artery bypass graft surgery patients (85%). Cognitive decline was present in 82 (34.2%) of 240 coronary artery bypass graft surgery patients and in 16 (16.2%) of 99 control subjects (crude odds ratio, 2.69; 95% confidence interval, 1.48 to 4.90). However, after correction for differences in age, sex, education, and baseline comorbidity between the patients and the control subjects, the odds ratio was 1.37 (95% confidence interval, 0.65 to 2.92).
Conclusions: We were unable to demonstrate that patients who underwent coronary artery bypass graft surgery have more cognitive decline after 5 years than control subjects without coronary artery disease.
| Introduction |
|---|
|
|
|---|
This result raised the hypothesis that the high incidence of long-term postoperative cognitive decline after CABG may be less related to the use of cardiopulmonary bypass or any other feature of the operation, but merely reflects normal aging [6]. This prompted us to appreciate the long-term cognitive status of CABG patients relative to the natural change in cognitive function with time. We therefore compared the 5-year neuropsychological performance of the CABG patients who were included in the Octopus Study with the cognitive status of similarly aged control subjects who had not undergone CABG.
| Patients and Methods |
|---|
|
|
|---|
To measure the natural variation in performance and practice effects during repeated neuropsychological testing, we have also studied a group of 112 control subjects. They were recruited between April 2000 and March 2001 through an advertisement in a local newspaper, age-matched to the CABG patients included in the Octopus Study, but not suffering from coronary artery disease [8]. The natural variation in cognitive performance observed in these control subjects during a short period of 3 months has been reported elsewhere [8].
To evaluate the difference in long-term cognitive decline between CABG patients and subjects who did not undergo CABG, we now compared neuropsychological test performance at 5-year follow-up between both cohorts. The study was approved by the medical ethics committees of the participating centers.
Design
The present study was a nonrandomized age-matched cohort study comparing long-term cognitive outcomes of CABG patients and control subjects without coronary artery disease.
Outcome Measure (Cognitive Decline)
The CABG patients and the control subjects underwent the same cognitive assessment at two points in time, with an interval of 5 years. For the CABG patients, the neuropsychological test battery was administered on the day before and 5 years after their surgery. Patients and control subjects underwent additional assessments 3 and 12 months after baseline assessment; the results of these latter two assessments have been reported elsewhere [7, 8].
The test battery comprised seven neuropsychological tests with eight main variables and was executed by trained psychologists. Testing procedures were similar for control subjects and patients [8]. In accordance with the Statement of Consensus on Assessment of Neurobehavioral Outcomes after Cardiac Surgery, the test battery included tests for motor skills, verbal memory capacity, and attention [9]. Each test yielded one or more variables, with different ranges per variable. Eight main variables were chosen a priori to be used in the analysis. The cognitive domains that were covered, the tests, and the eight main variables are listed in the Results section.
To determine the presence of cognitive decline, each individuals performance on the neuropsychological tests at 5-year follow-up was compared with his or her performance on the same tests 5 year earlier. Cognitive decline was defined as deterioration beyond the normal variation in cognitive performance. The normal variation in performance was measured in a short interval of 3 months in the control population (baseline assessment and 3-month follow-up). To define cognitive decline at 5 years in both the patients and the control subjects, the scores of the eight main variables were first standardized using the formula of reliable change (RC) as proposed by Jacobson and Truax [10]:
|
|
Patients and control subjects who had experienced a stroke and subjects unable to undergo testing because of Alzheimers disease were also considered to have cognitive decline.
Data Analysis
Incidences of cognitive decline after 5 years in patients and control subjects were compared using the odds ratio and 95% confidence interval, with adjustment for possible remaining differences in age between the two groups. Multivariable logistic regression analysis was used to correct for other baseline differences between the patients and the control subjects, and thus for potential confounding. We considered the following potential confounders: female sex, years of education, diabetes, hypertension, and pulmonary disease. All reported probability values are two-sided.
| Results |
|---|
|
|
|---|
|
|
|
|
| Comment |
|---|
|
|
|---|
This study compared the 5-year cognitive outcome of CABG patients to that of "healthy" control subjects. In 2001, Newman and colleagues [2] reported an alarming 42% incidence of cognitive decline 5 years after CABG, but this was an uncontrolled study. The results of the present study indicate that long-term cognitive decline also frequently occurs in similarly aged subjects who did not undergo CABG. This suggests that cognitive decline in CABG patients, as detected with repeated neuropsychological testing, is also partly the result of natural aging [6]. Despite the fact that the subjects in the control group had no coronary artery disease, we were unable to show that they had statistically significantly less cognitive decline than the CABG patients.
Several groups have recently suggested that the previously reported cognitive decline during the early postoperative period after CABG is transient and reversible [11, 12]. This has even led to the question of whether postoperative cognitive decline exists or whether it is a consequence of inadequate or misinterpreted neuropsychological test batteries [13]. It is therefore obvious that non-CABG control groups are needed for interpreting longitudinal changes in cognitive performance after CABG [8, 11, 14]. Selecting an appropriate control group, however, is difficult. Studies using control groups consisting of patients with coronary artery disease who did not undergo CABG have also suggested that undergoing CABG is not a major determinant of unfavorable neuropsychological outcome [15–17]. Two trials evaluated cognitive performance in patients randomized to CABG or percutaneous coronary intervention, and both failed to demonstrate a difference between the two patient categories [16, 17]. A study comparing patients with coronary disease with healthy control subjects indicated that the patients have a higher risk of cognitive impairment even before they undergo coronary revascularization [15]. This is confirmed by other studies reporting that cardiovascular risk factors predict lower performance on neuropsychological tests [18, 19]. Diffusion-weighted magnetic resonance imaging has shown new ischemic lesions in 11% to 15% of patients who underwent coronary angiography [20]. We therefore deliberately selected control subjects who were not suffering from coronary artery disease and who were unlikely to undergo a coronary intervention. As expected, the patients with coronary artery disease in the present study had a lower cognitive performance than the age-matched control subjects at baseline and at 5-year follow-up. However, the amount of decline in cognitive function after a period of 5 years was not statistically different between the patients with coronary artery disease and the control subjects, despite the fact that the patients had undergone CABG.
It is possible that the confidence interval of the adjusted odds ratio would not have included 1 (statistically significant) if the number of subjects had been greater. However, both the patient group and the control group are larger than in any study on long-term postoperative cognitive decline reported so far. Also, the loss to follow-up (12% in the control subjects and 15% in the CABG patients) is satisfactory compared with all other studies reporting long-term cognitive outcomes [2, 21]. The control subjects, although age-matched, were better educated. This appeared to have a strong influence on their risk of cognitive decline. The initially better cognitive outcome in the control subjects largely disappeared after correcting for this confounder.
In conclusion, we were unable to demonstrate that patients who underwent CABG have more cognitive decline after 5 years than control subjects without coronary artery disease.
| Appendix |
|---|
| Acknowledgments |
|---|
|
|
|---|
| Footnotes |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
P. J. Tully, R. A. Baker, J. L. Knight, D. A. Turnbull, and H. R. Winefield Neuropsychological Function 5 Years after Cardiac Surgery and the Effect of Psychological Distress Arch Clin Neuropsychol, October 29, 2009; (2009) acp082v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. van Dijk and C. J. Kalkman Why Are Cerebral Microemboli Not Associated with Cognitive Decline? Anesth. Analg., October 1, 2009; 109(4): 1006 - 1008. [Full Text] [PDF] |
||||
![]() |
Y.-H. Liu, D.-X. Wang, L.-H. Li, X.-M. Wu, G.-J. Shan, Y. Su, J. Li, Q.-J. Yu, C.-X. Shi, Y.-N. Huang, et al. The Effects of Cardiopulmonary Bypass on the Number of Cerebral Microemboli and the Incidence of Cognitive Dysfunction After Coronary Artery Bypass Graft Surgery Anesth. Analg., October 1, 2009; 109(4): 1013 - 1022. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Rosengart Invited commentary Ann. Thorac. Surg., January 1, 2008; 85(1): 64 - 64. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |